Safety Alerts

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd)

Published
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) EL(26)A/27 DMRC reference number: DMRC- 39320587 Date issued: 4 June 2026 Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to [...]

The post MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts